The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Machine and deep learning approaches for cancer drug repurposing
Open accessAbstract
Knowledge of the underpinnings of cancer initiation, progression and metastasis has increased exponentially in recent years. Advanced “omics” coupled with machine learning and artificial intelligence (deep learning) methods have helped elucidate targets and pathways critical to those processes that may be amenable to pharmacologic modulation. However, the current anti-cancer therapeutic armamentarium continues to lag behind. As the cost of developing a new drug remains prohibitively expensive, repurposing of existing approved and investigational drugs is sought after given known safety profiles and reduction in the cost barrier. Notably, successes in oncologic drug repurposing have been infrequent. Computational in-silico strategies have been developed to aid in modeling biological processes to find new disease-relevant targets and discovering novel drug-target and drug-phenotype associations. Machine and deep learning methods have especially enabled leaps in those successes. This review will discuss these methods as they pertain to cancer biology as well as immunomodulation for drug repurposing opportunities in oncologic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
(2014) · Cited by 33,419
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
NCBI GEO: archive for functional genomics data sets—update
Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1193 · Cited by 10,418
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Extended-Connectivity Fingerprints
Rogers, D., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,524
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Carpenter, A. E., Jones, T. R., Lamprecht, M. R., Clarke, C., Kang, I. H., Friman, O., Guertin, D. A., Chang, J. H., Lindquist, R. A., Moffat, J., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-10-r100 · Cited by 5,157
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515
PubChem 2019 update: improved access to chemical data
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1033 · Cited by 3,249
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
Principles of QSAR models validation: internal and external
Gramatica, P. (2007) · QSAR & Combinatorial Science · doi:10.1002/qsar.200610151 · Cited by 2,208
Immune checkpoint inhibitors: recent progress and potential biomarkers
Darvin, P., Toor, S. M., Sasidharan Nair, V., & Elkord, E. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0191-1 · Cited by 2,035
DeepDTA: deep drug–target binding affinity prediction
Öztürk, H., Özgür, A., & Ozkirimli, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty593 · Cited by 1,696
Predicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Gilson, M. K., Liu, T., Baitaluk, M., Nicola, G., Hwang, L., & Chong, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1072 · Cited by 1,628
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625 · cited 1×
“A detailed discussion of the mechanisms of immune evasion can be found in the following reference (94).”
BackgroundAn Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J., & Bradfield, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903670 · Cited by 1,601
Deep learning for computational biology
Angermueller, C., Pärnamaa, T., Parts, L., & Stegle, O. (2016) · Molecular Systems Biology · doi:10.15252/msb.20156651 · Cited by 1,473
Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., & Mellor, A. L. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.013 · Cited by 1,272
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.-L., Latreche, S., Bergaya, S., Benhamouda, N., Tanchot, C., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140559 · Cited by 1,179
Wang, R., Fang, X., Lu, Y., & Wang, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030580l · Cited by 1,133
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,047
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
Munn, D. H., & Mellor, A. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.001 · Cited by 1,037
KDEEP: Protein–Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks
Jiménez, J., Škalič, M., Martínez-Rosell, G., & De Fabritiis, G. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00650 · Cited by 926
DOCK 6: Impact of new features and current docking performance
Allen, W. J., Balius, T. E., Mukherjee, S., Brozell, S. R., Moustakas, D. T., Lang, P. T., Case, D. A., Kuntz, I. D., & Rizzo, R. C. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.23905 · Cited by 833
Antiangiogenic therapy in oncology: current status and future directions
Jayson, G. C., Kerbel, R., Ellis, L. M., & Harris, A. L. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01088-0 · Cited by 828
Sirota, M., Dudley, J. T., Kim, J., Chiang, A. P., Morgan, A. A., Sweet-Cordero, A., Sage, J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001318 · Cited by 799
Protein–Ligand Scoring with Convolutional Neural Networks
Ragoza, M., Hochuli, J., Idrobo, E., Sunseri, J., & Koes, D. R. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00740 · Cited by 774
BioLiP: a semi-manually curated database for biologically relevant ligand–protein interactions
Yang, J., Roy, A., & Zhang, Y. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks966 · Cited by 759
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Auslander, N., Zhang, G., Lee, J. S., Frederick, D. T., Miao, B., Moll, T., Tian, T., Wei, Z., Madan, S., Sullivan, R. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0157-9 · Cited by 738
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
Krieg, C., Nowicka, M., Guglietta, S., Schindler, S., Hartmann, F. J., Weber, L. M., Dummer, R., Robinson, M. D., Levesque, M. P., & Becher, B. (2018) · Nature Medicine · doi:10.1038/nm.4466 · Cited by 735
Can you teach old drugs new tricks?
Nosengo, N. (2016) · Nature · doi:10.1038/534314a · Cited by 729
OncomiRs: the discovery and progress of microRNAs in cancers
Cho, W. C. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-60 · Cited by 719
Terme, M., Pernot, S., Marcheteau, E., Sandoval, F., Benhamouda, N., Colussi, O., Dubreuil, O., Carpentier, A. F., Tartour, E., & Taieb, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2325 · Cited by 684
Wang, Y., Bryant, S. H., Cheng, T., Wang, J., Gindulyte, A., Shoemaker, B. A., Thiessen, P. A., He, S., & Zhang, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1118 · Cited by 671
Chen, Y.-C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.12.001 · Cited by 611
Aliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610
Exploiting machine learning for end-to-end drug discovery and development
Ekins, S., Puhl, A. C., Zorn, K. M., Lane, T. R., Russo, D. P., Klein, J. J., Hickey, A. J., & Clark, A. M. (2019) · Nature Materials · doi:10.1038/s41563-019-0338-z · Cited by 578
Deng, Z., Chuaqui, C., & Singh, J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030331x · Cited by 563
The CPTAC Data Portal: A Resource for Cancer Proteomics Research
Edwards, N. J., Oberti, M., Thangudu, R. R., Cai, S., McGarvey, P. B., Jacob, S., Madhavan, S., & Ketchum, K. A. (2015) · Journal of Proteome Research · doi:10.1021/pr501254j · Cited by 558
Mace, T. A., Shakya, R., Pitarresi, J. R., Swanson, B., McQuinn, C. W., Loftus, S., Nordquist, E., Cruz-Monserrate, Z., Yu, L., Young, G., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-311585 · Cited by 539
Keenan, A. B., Jenkins, S. L., Jagodnik, K. M., Koplev, S., He, E., Torre, D., Wang, Z., Dohlman, A. B., Silverstein, M. C., Lachmann, A., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2017.11.001 · Cited by 423
Self-citationLi, Y., Han, L., Liu, Z., & Wang, R. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500081m · Cited by 382
Unravelling biology and shifting paradigms in cancer with single-cell sequencing
Baslan, T., & Hicks, J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.58 · Cited by 381
FAIRsharing as a community approach to standards, repositories and policies
Community, T. F., Sansone, S.-A., McQuilton, P., Rocca-Serra, P., Gonzalez-Beltran, A., Izzo, M., Lister, A. L., & Thurston, M. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0080-8 · Cited by 364
Jahchan, N. S., Dudley, J. T., Mazur, P. K., Flores, N., Yang, D., Palmerton, A., Zmoos, A.-F., Vaka, D., Tran, K. Q. T., Zhou, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0183 · Cited by 358
PharmGKB: A worldwide resource for pharmacogenomic information
Barbarino, J. M., Whirl‐Carrillo, M., Altman, R. B., & Klein, T. E. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1417 · Cited by 358
A Breakthrough: Macrophage-Directed Cancer Immunotherapy
Mills, C. D., Lenz, L. L., & Harris, R. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1737 · Cited by 356
Kadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350
Sastry, M., Lowrie, J. F., Dixon, S. L., & Sherman, W. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100062n · Cited by 332
Targeting potassium channels in cancer
Huang, X., & Jan, L. Y. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201404136 · Cited by 330
Control of the Immune Response by Pro-Angiogenic Factors
Voron, T., Marcheteau, E., Pernot, S., Colussi, O., Tartour, E., Taieb, J., & Terme, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00070 · Cited by 325
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
Wang, D., Quiros, J., Mahuron, K., Pai, C.-C., Ranzani, V., Young, A., Silveria, S., Harwin, T., Abnousian, A., Pagani, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.050 · Cited by 318
sc-PDB: a 3D-database of ligandable binding sites—10 years on
Desaphy, J., Bret, G., Rognan, D., & Kellenberger, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku928 · Cited by 300
Immunosuppressive Activities of Adenosine in Cancer
Allard, B., Beavis, P. A., Darcy, P. K., & Stagg, J. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.04.001 · Cited by 292
Surflex-Dock: Docking benchmarks and real-world application
Spitzer, R., & Jain, A. N. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9533-y · Cited by 282
Cancer transcriptome profiling at the juncture of clinical translation
Cieślik, M., & Chinnaiyan, A. M. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.96 · Cited by 269
Scoring functions for protein-ligand docking.
Bentham Science Publisher, B. S. P. (2006) · Current Protein & Peptide Science · doi:10.2174/138920306778559395 · Cited by 258
Molecular similarity and diversity in chemoinformatics: From theory to applications
Maldonado, A. G., Doucet, J. P., Petitjean, M., & Fan, B.-T. (2006) · Molecular Diversity · doi:10.1007/s11030-006-8697-1 · Cited by 241
Rifaioglu, A. S., Nalbat, E., Atalay, V., Martin, M. J., Cetin-Atalay, R., & Doğan, T. (2020) · Chemical Science · doi:10.1039/c9sc03414e · Cited by 240
Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery
Simm, J., Klambauer, G., Arany, A., Steijaert, M., Wegner, J. K., Gustin, E., Chupakhin, V., Chong, Y. T., Vialard, J., Buijnsters, P., et al. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.01.015 · Cited by 232
SM2miR: a database of the experimentally validated small molecules’ effects on microRNA expression
Liu, X., Wang, S., Meng, F., Wang, J., Zhang, Y., Dai, E., Yu, X., Li, X., & Jiang, W. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts698 · Cited by 226
A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
Leone, R. D., Lo, Y.-C., & Powell, J. D. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.03.008 · Cited by 225
Predicting drug response of tumors from integrated genomic profiles by deep neural networks
Chiu, Y.-C., Chen, H.-I. H., Zhang, T., Zhang, S., Gorthi, A., Wang, L.-J., Huang, Y., & Chen, Y. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0460-9 · Cited by 225
Adenosine receptors and cancer
Gessi, S., Merighi, S., Sacchetto, V., Simioni, C., & Borea, P. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.09.020 · Cited by 224
Xu, H., Aldrich, M. C., Chen, Q., Liu, H., Peterson, N. B., Dai, Q., Levy, M., Shah, A., Han, X., Ruan, X., et al. (2015) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002649 · Cited by 218
Regulatory T cells: a potential target in cancer immunotherapy
Shitara, K., & Nishikawa, H. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13625 · Cited by 214
Koleti, A., Terryn, R., Stathias, V., Chung, C., Cooper, D. J., Turner, J. P., Vidović, D., Forlin, M., Kelley, T. T., D’Urso, A., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1063 · Cited by 193
Self-citationKim, J., Lahl, K., Hori, S., Loddenkemper, C., Chaudhry, A., deRoos, P., Rudensky, A., & Sparwasser, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804308 · Cited by 180
Chen, X., Guan, N.-N., Sun, Y.-Z., Li, J.-Q., & Qu, J. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby098 · Cited by 177
Da, C., & Kireev, D. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500319f · Cited by 172
Machine learning and image-based profiling in drug discovery
Scheeder, C., Heigwer, F., & Boutros, M. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.05.004 · Cited by 169
Predicting New Indications for Approved Drugs Using a Proteochemometric Method
Dakshanamurthy, S., Issa, N. T., Assefnia, S., Seshasayee, A., Peters, O. J., Madhavan, S., Uren, A., Brown, M. L., & Byers, S. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300576q · Cited by 168
Self-citationImmune‐suppressive effects of interleukin‐6 on T‐cell‐mediated anti‐tumor immunity
Tsukamoto, H., Fujieda, K., Senju, S., Ikeda, T., Oshiumi, H., & Nishimura, Y. (2018) · Cancer Science · doi:10.1111/cas.13433 · Cited by 167
Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models
Zhang, T., Zhang, L., Payne, P. R. O., & Li, F. (2021) · Methods in Molecular Biology · doi:10.1007/978-1-0716-0849-4_12 · Cited by 167
Cyclooxygenases and lipoxygenases in cancer
Schneider, C., & Pozzi, A. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9310-3 · Cited by 158
Nguyen, D. D., Cang, Z., Wu, K., Wang, M., Cao, Y., & Wei, G.-W. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-018-0146-6 · Cited by 155
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
Taylor, N., Vick, S. C., Iglesia, M. D., Brickey, W. J., Midkiff, B. R., McKinnon, K. P., Reisdorf, S., Anders, C. K., Carey, L., Parker, J. S., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90499 · Cited by 155
Cheng, H.-W., Liang, Y.-H., Kuo, Y.-L., Chuu, C.-P., Lin, C.-Y., Lee, M. H., Wu, A. T. H., Yeh, C.-T., Chen, E. I.-T., Whang-Peng, J., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.77 · Cited by 152
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
Visser, U., Abeyruwan, S. W., Vempati, U. D., Smith, R. P., Lemmon, V., & Schürer, S. C. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-257 · Cited by 128
Self-citationSarntivijai, S., Lin, Y., Xiang, Z., Meehan, T. F., Diehl, A. D., Vempati, U. D., Schürer, S. C., Pang, C., MALONE, J. M., Parkinson, H., et al. (2014) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-5-37 · Cited by 127
Self-citationBok, E., Chung, Y. C., Kim, K., Baik, H. H., Shin, W.-H., & Jin, B. K. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0111-4 · Cited by 126
Cortés‐Ciriano, I., Murrell, D. S., van Westen, G. J. P., Bender, A., & Malliavin, T. E. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-014-0049-z · Cited by 118
Tang, G. H., Satkunam, M., Pond, G. R., Steinberg, G. R., Blandino, G., Schünemann, H. J., & Muti, P. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0936 · Cited by 117
Metabolite and Microbiome Interplay in Cancer Immunotherapy
Johnson, C. H., Spilker, M. E., Goetz, L. H., Peterson, S. N., & Siuzdak, G. E. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0309 · Cited by 109
Drug and disease signature integration identifies synergistic combinations in glioblastoma
Stathias, V., Jermakowicz, A. M., Maloof, M. E., Forlin, M., Walters, W. M., Suter, R. K., Durante, M. A., Williams, S. L., Harbour, J. W., Volmar, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07659-z · Cited by 106
Self-citationLiu, X., Ye, K., van Vlijmen, H., IJzerman, A. P., & van Westen, G. J. P. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0355-6 · Cited by 106
Network-Based Approaches in Drug Discovery and Early Development
Harrold, J. M., Ramanathan, M. K., & Mager, D. E. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.176 · Cited by 105
Exploiting polypharmacology for drug target deconvolution
Gujral, T. S., Peshkin, L., & Kirschner, M. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403080111 · Cited by 102
Evolving BioAssay Ontology (BAO): modularization, integration and applications
Abeyruwan, S. W., Vempati, U. D., Küçük‐McGinty, H., Visser, U., Koleti, A., Mir, A., Sakurai, K., Chung, C., Bittker, J. A., Clemons, P. A., et al. (2014) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-5-s1-s5 · Cited by 102
Self-citationAlam, S., & Khan, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-06131-0 · Cited by 98
Deep learning-based transcriptome data classification for drug-target interaction prediction
Xie, L., He, S., Song, X., Bo, X., & Zhang, Z. (2018) · BMC Genomics · doi:10.1186/s12864-018-5031-0 · Cited by 98
Predicting protein-ligand binding residues with deep convolutional neural networks
Cui, Y., Dong, Q., Hong, D., & Wang, X. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2672-1 · Cited by 98
Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway
Brum, A. M., van de Peppel, J., van der Leije, C. S., Schreuders‐Koedam, M., Eijken, M., van der Eerden, B. C. J., & van Leeuwen, J. P. T. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501597112 · Cited by 96
Liu, J., Blake, S. J., Harjunpää, H., Fairfax, K. A., Yong, M. C. R., Allen, S. M., Kohrt, H. E. K., Takeda, K., Smyth, M. J., & Teng, M. W. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0194 · Cited by 95
Applications of Metabolomics in Cancer Studies
Armitage, E. G., & Ciborowski, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-47656-8_9 · Cited by 95
Molenaar, R. J. (2011) · ISRN Neurology · doi:10.5402/2011/590249 · Cited by 81
Li, F., Liu, W., & Yu, H. Q. (2018) · JMIR Medical Informatics · doi:10.2196/12159 · Cited by 81
Advancing the activity cliff concept
Hu, Y., Stumpfe, D., & Bajorath, J. (2013) · F1000Research · doi:10.12688/f1000research.2-199.v1 · Cited by 78
Pairet, N., Mang, S., Fois, G., Keck, M., Kühnbach, M., Gindele, J., Frick, M., Dietl, P., & Lamb, D. J. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196055 · Cited by 76
Drug target ontology to classify and integrate drug discovery data
Lin, Y., Mehta, S., Küçük‐McGinty, H., Turner, J. P., Vidović, D., Forlin, M., Koleti, A., Nguyễn, Ð.-T., Jensen, L. J., Guha, R., et al. (2017) · Journal of Biomedical Semantics · doi:10.1186/s13326-017-0161-x · Cited by 71
Self-citationAlgamal, Z. Y., Lee, M. H., Al‐Fakih, A. M., & Aziz, M. (2015) · Journal of Chemometrics · doi:10.1002/cem.2741 · Cited by 70
DPubChem: a web tool for QSAR modeling and high-throughput virtual screening
Soufan, O., Ba-Alawi, W., Magana-Mora, A., Essack, M., & Bajić, V. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-27495-x · Cited by 68
Small-Molecule Targets in Immuno-Oncology
Dhanak, D., Edwards, J. P., Nguyen, A., & Tummino, P. J. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.019 · Cited by 67
Al‐Ali, H., Lee, D.-H., Danzi, M. C., Nassif, H., Gautam, P., Wennerberg, K., Zuercher, B., Drewry, D. H., Lee, J. K., Lemmon, V., et al. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00289 · Cited by 66
Wang, C.-C., Chen, X., Qu, J., Sun, Y., & Li, J. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00129 · Cited by 66
Tomar, S., Zumbrun, E. E., Nagarkatti, M., & Nagarkatti, P. S. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220368 · Cited by 63
Mirza, S. B., Salmas, R. E., Fatmi, M. Q., & Durdağı, S. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.03.008 · Cited by 60
Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed
Eid, R. A., Razavi, G. S. E., Mkrtichyan, M., Janik, J. E., & Khleif, S. N. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0048 · Cited by 60
Turning the Tide Against Regulatory T Cells
Han, S., Toker, A., Liu, Z. Q., & Ohashi, P. S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00279 · Cited by 60
Vempati, U. D., Przydzial, M. J., Chung, C., Abeyruwan, S. W., Mir, A., Sakurai, K., Visser, U., Lemmon, V., & Schürer, S. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049198 · Cited by 59
Self-citationIn Silico Prediction of Small Molecule-miRNA Associations Based on the HeteSim Algorithm
Qu, J., Chen, X., Sun, Y., Zhao, Y. F., Cai, S., Ming, Z., You, Z., & Li, J. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.12.002 · Cited by 59
Virtual screening strategies: Recent advances in the identification and design of anti-cancer agents
Kumar, V., Krishna, S., & Siddiqi, M. I. (2014) · Methods · doi:10.1016/j.ymeth.2014.08.010 · Cited by 58
Kinome-wide Activity Modeling from Diverse Public High-Quality Data Sets
Schürer, S. C., & Muskal, S. M. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300403k · Cited by 58
Self-citationKundu, I., Paul, G., & Banerjee, R. (2018) · RSC Advances · doi:10.1039/c8ra00003d · Cited by 58
van Westen, G. J. P., van den Hoven, O. O., van der Pijl, R., Mulder‐Krieger, T., de Vries, H., Wegner, J. K., IJzerman, A. P., van Vlijmen, H., & Bender, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003069 · Cited by 54
Kang, D., Pang, X., Lian, W., Xu, L., Wang, J., Jia, H., Zhang, B., Liu, A., & Du, G. (2018) · RSC Advances · doi:10.1039/c7ra12259d · Cited by 53
Tian, S., Wang, X., Li, L., Zhang, X., Li, Y., Zhu, F., Hou, T., & Zhen, X. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00188 · Cited by 51
Hafeez, B. B., Ganju, A., Sikander, M., Kashyap, V. K., Hafeez, Z. B., Chauhan, N., Malik, S., Massey, A. E., Tripathi, M. K., Halaweish, F. T., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0157 · Cited by 49
Shao, Y. M., Ma, X., Paira, P., Tan, A., Herr, D. R., Lim, K. L., Ng, C. H., Venkatesan, G., Klotz, K., Federico, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0188212 · Cited by 49
Computational analysis and predictive modeling of small molecule modulators of microRNA
Jamal, S., Periwal, V., & Scaria, V. (2012) · Journal of Cheminformatics · doi:10.1186/1758-2946-4-16 · Cited by 46
Gautam, P., Jaiswal, A., Aittokallio, T. A., Al‐Ali, H., & Wennerberg, K. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2019.03.011 · Cited by 46
EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy
Zhou, X., Wang, M., Katsyv, I., Irie, H., & Zhang, B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty325 · Cited by 43
LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent
Han, H. W., Hahn, S., Jeong, H. Y., Jee, J., Nam, M.-O., Kim, H. K., Lee, D. H., Lee, S., Choi, D. K., Yu, J. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33039-0 · Cited by 41
Using the Connectivity Map to discover compounds influencing human osteoblast differentiation
Brum, A. M., van de Peppel, J., Nguyen, L., Aliev, A., Schreuders‐Koedam, M., Gajadien, T., van der Leije, C. S., van Kerkwijk, A., Eijken, M., van Leeuwen, J. P. T. M., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26298 · Cited by 40
Sustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration Center
Stathias, V., Koleti, A., Vidović, D., Cooper, D. J., Jagodnik, K. M., Terryn, R., Forlin, M., Chung, C., Torre, D., Ayad, N. G., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.117 · Cited by 36
Self-citationDeshmukh, A. L., Chandra, S., Singh, D. K., Siddiqi, M. I., & Banerjee, D. (2017) · Molecular BioSystems · doi:10.1039/c7mb00118e · Cited by 34
Johnson, T. S., McGaha, T. L., & Munn, D. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_7 · Cited by 33
Taha, M. O., Al-Sha’er, M. A., Khanfar, M. A., & Al-Nadaf, A. H. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.056 · Cited by 32
Representing high throughput expression profiles via perturbation barcodes reveals compound targets
Filzen, T. M., Kutchukian, P. S., Hermes, J. D., Li, J., & Tudor, M. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005335 · Cited by 31
Identification of novel hair‐growth inducers by means of connectivity mapping
Ishimatsu‐Tsuji, Y., Soma, T., & Kishimoto, J. (2009) · The FASEB Journal · doi:10.1096/fj.09-145292 · Cited by 31
Large Scale Semi-Automated Labeling of Routine Free-Text Clinical Records for Deep Learning
Trivedi, H., Panahiazar, M., Liang, A. S., Lituiev, D., Chang, P., Sohn, J. H., Chen, Y., Franc, B. L., Joe, B. N., & Hadley, D. (2018) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-018-0105-8 · Cited by 30
Discovery of indoleamine 2,3-dioxygenase inhibitors using machine learning based virtual screening
Zhang, H., Liu, W., Liu, Z., Ju, Y., Xu, M., Zhang, Y., Wu, X., Gu, Q., Wang, Z., & Xu, J. (2018) · MedChemComm · doi:10.1039/c7md00642j · Cited by 28
Praziquantel Targets M1 Macrophages and Ameliorates Splenomegaly in Chronic Schistosomiasis
Kong, D., Zhou, C., Guo, H., Wang, W. T., Qiu, J., Liu, X., Liu, J., Wang, L., & Wang, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00005-17 · Cited by 27
Kandela, I. K., Aird, F., & Reproducibility Project: Cancer Biology (2017) · eLife · doi:10.7554/elife.17044 · Cited by 26
Michielan, L., Bolcato, C., Federico, S., Cacciari, B., Bacilieri, M., Klotz, K., Kachler, S., Pastorin, G., Cardin, R., Sperduti, A., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.038 · Cited by 24
Zador, Z. E., King, A. T., & Geifman, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194701 · Cited by 21
Vanderstocken, G., Dvorkin‐Gheva, A., Shen, P., Brandsma, C., Obeidat, M., Bossé, Y., Hassell, J. A., & Stämpfli, M. R. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0202oc · Cited by 17
Automated Detection of Systematic Off-label Drug Use in Free Text of Electronic Medical Records.
Jung, K., LePendu, P., & Shah, N. H. (2013) · Europe PMC (PubMed Central) · Cited by 15
The Puzzle of Predicting Response to Immune Checkpoint Blockade
Onyshchenko, M. I. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.020 · Cited by 15
Towards In Silico Prediction of the Immune-Checkpoint Blockade Response
Chen, K., Ye, H., Lu, X., Sun, B., & Liu, Q. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.10.002 · Cited by 14
Discovery of novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors by virtual screening
Zhou, Y., Peng, J., Li, P., Du, H., Li, Y., Li, Y., Zhang, L., Sun, W., Liu, X., & Zuo, Z. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.11.024 · Cited by 13
Wang, Y., Lin, H., Wang, P., Hu, J., Ip, T.-M., Yang, L.-M., Zheng, Y., & Wan, D. C. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00402 · Cited by 9
Kinome-Wide Activity Classification of Small Molecules by Deep LearningPreprint
Allen, B. K., Ayad, N. G., & Schürer, S. C. (2019) · SSRN Electronic Journal · doi:10.1101/512459 · Cited by 8
Self-citationWallach, I., Dzamba, M., & Heifets, A. (2015) · arXiv · doi:10.48550/arxiv.1510.02855
Cited by
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Phenotypic drug discovery: recent successes, lessons learned and new directions
Vincent, F., Nueda, A., Lee, J., Schenone, M., Prunotto, M., & Mercola, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00472-w · Cited by 348
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Jin, P., Jiang, J., Zhou, L., Huang, Z., Nice, E. C., Huang, C., & Fu, L. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01313-4 · Cited by 273
Metadata
- Authors
- Issa, N. T., Stathias, V., Schürer, S., & Dakshanamurthy, S.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 68
- Pages
- 132-142
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2998322952
- Cited by
- 274
- References
- 153
- FWCI
- 12.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.